Based on these findings, we thought that FOXD1 upregulation confers radioresistance by downregulating the JAK-STAT pathway-mediated TXNIP expression, which may ultimately decrease and inactivate p53 in oral cancer (Figure 6). Here, FOXD1 is linked to lip and oral cavity carcinoma.